The activating natural killer (NK)-cell receptor KIR3DS1 has been linked to the outcome of various human diseases, including delayed progression of disease caused by human immunodeficiency virus type 1 (HIV-1), yet a ligand that would account for its biological effects has remained unknown. We screened 100 HLA class I proteins and found that KIR3DS1 bound to HLA-F, a result we confirmed biochemically and functionally. Primary human KIR3DS1(+) NK cells degranulated and produced antiviral cytokines after encountering HLA-F and inhibited HIV-1 replication in vitro. Activation of CD4(+) T cells triggered the transcription and surface expression of HLA-F mRNA and HLA-F protein, respectively, and induced binding of KIR3DS1. HIV-1 infection further increased the transcription of HLA-F mRNA but decreased the binding of KIR3DS1, indicative of a mechanism for evading recognition by KIR3DS1(+) NK cells. Thus, we have established HLA-F as a ligand of KIR3DS1 and have demonstrated cell-context-dependent expression of HLA-F that might explain the widespread influence of KIR3DS1 in human disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992421 | PMC |
| http://dx.doi.org/10.1038/ni.3513 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer.
Cancers (Basel)
December 2024
Department of Immunology, IML and IdISSC, Hospital Clinico San Carlos, 28040 Madrid, Spain.
Human leukocyte antigens (HLAs) are essential regulators of immune responses against cancer, with classical HLAs well-documented for their role in tumor recognition and immune surveillance. In recent years, non-classical HLAs-including HLA-E, HLA-F, HLA-G, and HLA-H-have emerged as critical players in the immune landscape of cancer due to their diverse and less conventional functions in immune modulation. These molecules exhibit unique mechanisms that enable tumors to escape immune detection, promote tumor progression, and contribute to therapeutic resistance.
View Article and Find Full Text PDFTGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma.
Int J Mol Sci
October 2024
Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA.
The treatment of pancreatic ductal adenocarcinoma (PDAC) is an unmet challenge, with the median overall survival rate remaining less than a year, even with the use of FOLFIRINOX-based therapies. This study analyzed archived macrophage-associated mRNA expression using datasets deposited in the UCSC Xena web platform to compare normal pancreatic tissue and PDAC tumor samples. The gene exhibited low mRNA expression levels in normal tissue, with less than one TPM.
View Article and Find Full Text PDFGenome-wide identification of cell type-specific susceptibility genes for Juvenile dermatomyositis through the analysis of N-methyladenosine-associated SNPs.
Autoimmunity
December 2024
Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Department of Epidemiology, School of Public Health, Suzhou Medical College of Soochow University, China.
Article Synopsis
- Genome-wide association studies (GWASs) have identified genetic regions linked to juvenile dermatomyositis (JDM), but the specific functional genes in these regions are still unclear.
- This study focused on mA-associated SNPs (mA-SNPs) in relevant cell types to determine their impact on gene expression in relation to JDM using bulk tissue and single-cell analyses.
- Seven mA-SNPs were associated with JDM, revealing differential expression of multiple genes, particularly in myeloid, T, and B cells of JDM patients, highlighting the complex relationship between mA-SNPs and disease susceptibility.
Mutated Adenovirus Attacks in West Bengal, India: Risk Evaluation of Multi-Country Outbreaks and Mitigation Strategies.
Nurs Open
October 2024
School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Article Synopsis
- The human adenovirus (HAdV) is rapidly spreading among children in India, with around 12,000 cases reported in 2022, posing a significant public health threat due to the lack of vaccines or preventative policies.
- Key strategies to combat HAdV outbreaks include early detection, isolation, and the implementation of effective treatment protocols, such as using antiviral drugs and cleaning surfaces.
- Ongoing research into antibody interactions and existing vaccines hints at potential future therapeutic options to better manage and control HAdV infections.
Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients.
Hum Immunol
November 2024
Centre for Immune Regulation and Reproductive Immunology (CIRRI), Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address:
Triple-negative breast cancer (TNBC) is usually aggressive and challenging to treat. With high tumour immunogenicity TNBC patients might benefit from immunotherapy. We evaluated heterogeneous immune profiles of individual tumours in relation to clinical development to identify immune markers and their mutual expression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!